SEC Form 4 · accession 0001179110-16-020726
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Bernard O'Connor
Officer — Chief Financial Officer
Period of report
Mar 1, 2016
Accepted (ET)
Mar 2, 2016 · 6:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2016 | A | 7,264 | $0.00 | A | 30,828 | D | |
| Common StockF2 | Mar 2, 2016 | F | 2,487 | $33.85 | D | 28,341 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F3 | $33.04 | Mar 1, 2016 | A | 47,644 | A | — | Mar 1, 2026 | Common Stock | 47,644 | 47,644 | D |
Explanation of responses
- F1Shares of restricted stock vest in 25% increments on each anniversary of the date of grant, until fully vested.
- F2Shares of common stock were withheld for payment of taxes in connection with the vesting of 6,588 shares of restricted stock from previously reported grants.
- F3The option vests in forty-eight equal installments beginning April 1, 2016.